Out come of board meeting held on today Thursday 14th August 2025 at 3.00 pm and concluded at 3.30 pm
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Triochem Products approved the unaudited standalone financial results for the quarter ended June 30, 2025. Total income from operations stood at Rs. 22.10 lakhs, down from Rs. 22.97 lakhs in the same quarter last year and Rs. 32.47 lakhs in the previous quarter (Q4 FY25). The company reported a net loss after tax of Rs. 3.06 lakhs in Q1 FY26, narrower than the Rs. 7.84 lakh loss in Q1 FY25 but still in the red. Basic and diluted EPS was negative at Rs. (1.25). Total comprehensive income was positive at Rs. 89.27 lakhs. Statutory auditor Kanu Doshi Associates LLP issued an unqualified limited review report. Management flagged that the company has temporarily reduced activity, citing lingering Covid-19 impact, shrinking customer business, and no near-term revival expected, but stated liquidity remains comfortable and obligations are being met on time.
For shareholders, this is a mixed-to-negative update: revenue continues to slip, the company remains loss-making at the operating level, and management's own commentary signals no near-term recovery in its core business. The comfortable liquidity position and unqualified auditor opinion are positives, but the outlook commentary is weak and could weigh on sentiment around the stock.